In prostate cancer, the expression of miRNA-195-5p decreases abnormally, and its ability to suppress the expression of FOSL1 decreases, which leads to an increase in the content of FOSL1 and promotes invasion and metastasis of the tumor. The gene discussed is FOSL1; the disease is prostate carcinoma.